Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8835423 Azepine inhibitors of janus kinases

Patent 8835423 was granted and assigned to Incyte on September, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Incyte
Incyte
Date Filed
September 20, 2013
Date of Patent
September 16, 2014
Patent Applicant
Incyte
Incyte
Patent Application Number
14032629
Patent Citations Received
‌
US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms
0
‌
US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors
0
‌
US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Patent Inventor Names
James D. Rodgers
0
Andrew P. Combs
0
Argyrios G. Arvanitis
0
Darius J. Robinson
0
Richard B. Sparks
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8835423
Patent Primary Examiner
‌
Charanjit Aulakh

Find more entities like US Patent 8835423 Azepine inhibitors of janus kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo